scholarly journals A Focus Group Exploration of Automated Case‐Finders to Identify High‐Risk Heart Failure Patients within an Urban Safety- Net Hospital

Author(s):  
Mark E. Patterson ◽  
Derick Miranda ◽  
Gregory L. Schuman ◽  
Christopher M. Eaton ◽  
Andrew J. Smith ◽  
...  
2020 ◽  
Vol 75 (11) ◽  
pp. 2291
Author(s):  
Faith Works-Fleming ◽  
Diane L. Wirth ◽  
Leslie H. Marshburn ◽  
Michael D. Knauss ◽  
Brandi N. Quinn ◽  
...  

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Paul J Marano ◽  
Alexandra B Steverson ◽  
Caren Chen ◽  
Yifei Ma ◽  
Rachel J Stern ◽  
...  

Introduction: Safety net hospitals are more likely to be penalized for heart failure (HF) readmissions. There is limited evidence as to whether readmission reduction strategies are effective in this setting. We hypothesized that a discharge checklist would reduce readmissions in an urban safety net hospital. Methods: We implemented a novel HF discharge checklist in an academic safety net hospital in San Francisco from October 2018 to April 2019. The checklist included 1) achievement of euvolemia based on physical exam, 2) prescription of guideline-directed medical therapy, and 3) establishment of scheduled follow-up within 7 days of discharge. All HF patients who were discharged with the checklist in the 6 month study period were retrospectively compared to all HF patients discharged in the 6 months prior to the implementation of the checklist. The primary outcome was the 30-day readmission rate and multivariate modeling was used to assess the significance of each checklist component. Results: Demographics were similar between the intervention (n=118) and control (n=265) groups. Of all 383 patients, mean age was 60±13 years, 102 (27%) patients were women, 170 (44%) were black, 88 (23%) were latinx, 127 (33%) were not housed, 208 (54%) used illicit substances, and 289 (76%) had ejection fraction ≤ 40%. Use of the checklist was associated with a 13.3% absolute reduction in the 30-day readmission rate (33.6% vs 20.3%, p=0.009). The intervention group was more likely to be discharged on guideline-directed medical therapy (54% vs 25%, p<0.0001) including beta blockers (89% vs 71%, p<0.0001), ACEI/ARBs (88% vs 66%, p<0.0001) and MRAs (50% vs 23%, p<0.0001). The intervention group was also more likely to have scheduled follow-up within 7 days (70 vs 58%, p=0.02). There was no difference between the groups in achievement of euvolemia. In all patients, multivariate analysis adjusted for demographics and insurance status demonstrated that the prescription of guideline-directed medical therapy was associated with lower risk of readmission (OR 0.31, 0.15-0.64). Conclusions: A novel, inexpensive discharge checklist increased the prescription of guideline-directed medical therapy and significantly reduced 30-day HF readmissions in a safety net hospital.


2018 ◽  
Vol 24 (8) ◽  
pp. S94 ◽  
Author(s):  
Ahmed B. Alsalem ◽  
Ziduo Zheng ◽  
Yijian Huang ◽  
Kathryn Norton ◽  
Diane Wirth ◽  
...  

2021 ◽  
Vol 264 ◽  
pp. 117-123
Author(s):  
Katherine F Vallès ◽  
Miriam Y Neufeld ◽  
Elisa Caron ◽  
Sabrina E Sanchez ◽  
Tejal S Brahmbhatt

2021 ◽  
Vol 10 (Supplement_1) ◽  
Author(s):  
J Plonka ◽  
J Bugajski ◽  
M Plonka ◽  
A Tycinska ◽  
M Gierlotka

Abstract Funding Acknowledgements Type of funding sources: None. Levosimendan, a calcium sensitizer and potassium channel-opener, is appreciated  for its effects on systemic and pulmonary hemodynamic and for the relief of symptoms in acute heart failure (AHF). Positive effects of levosimendan on renal function have been also described. The aim of the present analysis was to assess the predictors of the diuresis response to levosimendan administration in high risk acute heart failure patients. Methods. We analysed 34 consecutive patients admitted with high risk AHF to one centre and treated in intensive cardiac care unit. Levosimendan was administered on top of other treatment as a 24-hour infusion of 12.5 mg total dose except for 7 patients (1 patient - terminated earlier due to intolerance, 5 patients – 48h infusion, 1 patient - 72h infusion). Decision of levosimendan administration was based on clinical status and left to attending physician. Diuresis and diuretic dosage before (24 hours) and after levosimendan infusion (48 hours) were taken into account for the present study. Results. The AHF was primary of cardiac origin in all patients. In 6 (18%) it was due to recent acute myocardial infarction. In-hospital mortality was 24%. Median length of hospitalization was 26 days (range 6 to 107 days). Mean age of the patients was 66 ± 12 years, 25 (74%) were men. Mean INTERMACS score was 3.4 ± 1.4 with wet-cold clinical profile present in 13 (38%) of patients. Mean left ventricle ejection fraction (LVEF) was 27 ± 13%, mean NTproBNP was 17176 ± 12464 pg/ml, and mean eGFR 48 ± 22 ml/min/1.73m2. At the time of levosimendan administration patients had background treatment with catecholamines (mean number per patient 1.4 ± 1.1, range 0-3) and with diuretics (mean dosage of furosemide 167 ± 102 mg/24h, range 20-500). 48-hours diuresis after levosimendan administration varies from 950 to 11300 ml (mean 4307 ± 2418 ml). It was significantly lower in patients with cold-wet profile (2646 ± 1335 vs. 5335 ± 2381 ml in other clinical profiles, p = 0.0002). Additionally, 48-hour diuresis was negatively correlated with age (r=-0.46, p = 0.0062) and the number of background catecholamines (r=-0.47, p = 0.0047), and not significantly with the furosemide dosage (r=-0.28, p = 0.10) – figure. No association with diuresis was found for LVEF, NTproBNP, and eGFR. In multiple regression analysis (model R2 = 0.63, p = 0.0085) both older age (p = 0.026) and cold-wet profile (p = 0.0074) were significant predictors of poor diuresis after levosimendan administration. Conclusion. Older age and cold-wet profile were significant predictors of poor diuresis response to levosimendan administration in high risk acute heart failure patients. Although concomitant catecholamines and high diuretic dosage use cloud also be markers of non-responders to levosimendan in terms of diuresis. Abstract Figure


2018 ◽  
Vol 24 (8) ◽  
pp. S129
Author(s):  
Justin D. Roberts ◽  
Amanda Gerberich ◽  
Kathleen Makkar ◽  
Lisa Rathman

Heart ◽  
2015 ◽  
Vol 101 (Suppl 4) ◽  
pp. A15.1-A15
Author(s):  
Sarah Burgess ◽  
Lucy Cornthwaite

Public Health ◽  
2014 ◽  
Vol 128 (11) ◽  
pp. 1033-1035 ◽  
Author(s):  
J. Feigal ◽  
B. Park ◽  
C. Bramante ◽  
C. Nordgaard ◽  
J. Menk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document